TM6SF2 and type 2 diabetes mellitus: In contrast, TM6SF2 regulates qualitative triglyceride enrichment and lipid synthesis, resulting in lower circulating lipoproteins such as triglyceride and LDL cholesterol and lower risk for cardiovascular disease (CVD), but with higher risk for T2DM [16,18,37,39].